| Next-generation sequencing of host genetics risk factors associated with COVID-19 severity and long-COVID in Colombian population M Angulo-Aguado, JC Carrillo-Martinez, NC Contreras-Bravo, A Morel, ... Scientific Reports 14 (1), 8497, 2024 | | 2024 |
| Linking genotype to trophoblast phenotype in preeclampsia and HELLP syndrome associated with STOX1 genetic variants L Costa, L Bermudez-Guzman, I Benouda, P Laissue, A Morel, ... Iscience 27 (3), 2024 | | 2024 |
| P‐IG‐45| The RHAG* 01N. 26 Variant Does Not Lead to Rh‐Null but to Rh‐Mod Phenotype: The Importance of Absorption and Elusion Assays A Urbina, Y Flórez, M Hernández, A Rodriguez, N Contreras‐Bravo, ... Transfusion 63, 199A-199A, 2023 | | 2023 |
| Functional analysis of CTLA4 promoter variant and its possible implication in colorectal cancer immunotherapy M Angulo-Aguado, S Orjuela-Amarillo, JF Mora-Jácome, LP Córdoba, ... Frontiers in Medicine 10, 1160368, 2023 | | 2023 |
| Pharmacogenomic profile of actionable molecular variants related to drugs commonly used in anesthesia: WES analysis reveals new mutations JF Parada-Márquez, ND Maldonado-Rodriguez, P Triana-Fonseca, ... Frontiers in Pharmacology 14, 1047854, 2023 | 1 | 2023 |
| Performance Comparison of a Duplex Implementation of the CDC EUA 2019-nCoV Assay with the Seegene Allplex-SARS-CoV-2 Assay for the Detection of SARS-CoV-2 in Nasopharyngeal … KM Jiménez, DJ Fonseca-Mendoza, A Morel, O Ortega-Recalde, ... Methods and Protocols 5 (5), 73, 2022 | | 2022 |
| Characterization of ADME gene variation in Colombian population by exome sequencing DF Silgado-Guzmán, M Angulo-Aguado, A Morel, MJ Niño-Orrego, ... Frontiers in Pharmacology 13, 931531, 2022 | 6 | 2022 |
| Association between the LZTFL1 rs11385942 polymorphism and COVID-19 severity in Colombian population M Angulo-Aguado, D Corredor-Orlandelli, JC Carrillo-Martínez, ... Frontiers in Medicine 9, 910098, 2022 | 15 | 2022 |
| Abstract P3-07-05: Genetic profile of germline mutations in unselected women with breast cancer in a Colombian population DC Sierra-Díaz, A Morel, DJ Fonseca, N Contreras, M Angulo-Aguado, ... Cancer Research 82 (4_Supplement), P3-07-05-P3-07-05, 2022 | | 2022 |
| Preeclampsia, natural history, genes, and miRNAs associated with the syndrome L Parada-Niño, LF Castillo-León, A Morel Journal of Pregnancy 2022, 2022 | 15 | 2022 |
| Frecuencia de alteraciones germinales en genes de riesgo alto/moderado para riesgo de cáncer de mama hereditario: estudio multicéntrico en población no seleccionada WAM Durán, DCS Díaz, A Morel, N Contreras, MA Aguado, V Balaguera, ... Revista Colombiana de Hematología y Oncología 9 (Supl), 182-183, 2022 | | 2022 |
| Whole-exome sequencing in patients affected by Stevens-Johnson syndrome and toxic epidermal necrolysis reveals new variants potentially contributing to the phenotype DJ Fonseca, A Morel, K Llinás-Caballero, D Bolívar-Salazar, P Laissue Pharmacogenomics and personalized medicine, 287-299, 2021 | 4 | 2021 |
| A Novel Splice-Site Mutation in the ELN Gene Suggests an Alternative Mechanism for Vascular Elastinopathies CA Velandia-Piedrahita, A Morel, DJ Fonseca-Mendoza, ... The application of clinical genetics, 233-240, 2020 | 6 | 2020 |
| Identifying new potential genetic biomarkers for HELLP syndrome using massive parallel sequencing KM Jiménez, A Morel, L Parada-Niño, MA González-Rodriguez, S Flórez, ... Pregnancy hypertension 22, 181-190, 2020 | 13 | 2020 |
| The effect of the deletion of MIEN1 promoter region in colorectal cancer cell line HT29. P Chaudhary, D Sierra-diaz, J Vishwanatha, A Morel, J Buitrago, ... | | 2020 |
| DNA demethylation agent 5azadC downregulates HPV16 E6 expression in cervical cancer cell lines independently of TBX2 expression J Perrard, A Morel, K Meznad, P Paget‑Bailly, V Dalstein, D Guenat, ... Oncology Letters 19 (1), 1074-1081, 2020 | 7 | 2020 |
| Functional evidence implicating NOTCH2 missense mutations in primary ovarian insufficiency etiology LC Patiño, I Beau, A Morel, B Delemer, J Young, N Binart, P Laissue Human Mutation 40 (1), 25-30, 2019 | 19 | 2019 |
| A novel mutation in KHDRBS1 in a patient affected by primary ovarian insufficiency. C Carlosama, LC Patiño, I Beau, A Morel, B Delemer, J Young, N Binart, ... Clinical Endocrinology 89 (2), 2018 | 6 | 2018 |
| 5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression A Morel, A Baguet, J Perrard, C Demeret, E Jacquin, D Guenat, C Mougin, ... Oncotarget 8 (28), 46163, 2017 | 29 | 2017 |
| Régulation épigénétique des gènes précoces d'HPV16 A Morel Besançon, 2016 | | 2016 |
